Hair follicle scope for pemphigus activity
Part of Immune system & allergy, Skin clinical trials.
This study uses a special skin test called trichoscopy (a non-invasive way to look at hair follicles under a microscope) to check if your pemphigus vulgaris is active or in remission, and compares it with a blood test. It may help doctors monitor your disease without frequent invasive biopsies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of pemphigus vulgaris (based on a skin biopsy).
- Your pemphigus may be currently active or in remission (quiet phase).
- You cannot have other forms of pemphigus (such as pemphigus foliaceus).
- You must not have been treated with rituximab before.
- You cannot have any other skin condition or autoimmune disease (like lupus or rheumatoid arthritis).
- You cannot be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug called CM313 (an antibody that targets a protein on immune cells) for treating pemphigus, a condition that causes painful blisters on the skin and mouth. The goal is to see if it can reduce blisters and improve quality of life, especially for people who haven't responded well to other treatments.
This study compares a tailored “maintenance” treatment plan to the usual standard care in adults with newly diagnosed pemphigus (PV or PF). It aims to see whether the personalized approach can help control the disease while reducing the burden of long-term treatment.
This Phase 1/2 trial tests the safety and dosing of genetically modified immune cells made from your own blood (autologous CAR T or related cells) for active pemphigus vulgaris. It may help control disease that is not adequately managed with standard medicines.
This study tests a new medicine called CM313 for people with moderate to severe pemphigus, a condition that causes painful blisters on the skin and mouth. The goal is to see if CM313 can help reduce these blisters and improve quality of life.
This study is for adults with certain autoimmune blistering skin conditions. Researchers want to better understand and test treatments that could improve symptoms and healing for people with these specific diseases.
This study tests whether a steroid mouthwash and/or light therapy (photobiomodulation) can help heal painful mouth sores caused by pemphigus vulgaris, an autoimmune disease that damages the inside of the mouth and skin.
Hear when a new Pemphigus Vulgaris (PV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.